BEGIN:VCALENDAR VERSION:2.0 PRODID:icalendar-ruby CALSCALE:GREGORIAN BEGIN:VEVENT DTSTAMP:20240329T130940Z UID:b35db778-6388-427b-9a33-f1c5b6afa786 DTSTART:20211029T080000 DTEND:20211030T080000 CLASS:PRIVATE DESCRIPTION:
About Conference
\n\nCancer Science and Therapy conference invites Cancer Specialis ts\, Oncologists\, Professors\, Directors\, Students and Industrial profes sionals from USA\, Europe and Asia. Explore and learn more about Conferenc e Series LLC Ltd: World&lsquo\;s leading Event Organizer. Meet Global Onco logists\, Doctors\, Scientists Researchers and Industry Professionals from UK\, Europe\, USA\, Middle East\, and Asia at Cancer Therapy 2020.
\n\ n26th Annual Congress on Cancer Science and Therapy Date: October 29-30 \, 2020 San Francisco\, USA Venue: San Francisco\, USA
\n\nC ancer Therapy 2020 will be organized around the theme &ldquo\;Securing the Future of Innovation in Cancer Treatment&rdquo\;.
\n\nCanc er Therapy 2020 is comprised of many interactive scientific sessions on di fferent types of Cancer disorders as well as various diagnostic and therap eutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. Cancer Therapy 2020 welcomes t he Cancer Specialists\, Oncologists\, Professors\, Director&rsquo\;s\, Res earch scholars\, Student delegates and Industrial professionals from Biome dical and healthcare sectors to be a part of it in Cancer Therapy 2020
\n\nAccording to market study\, annual global growth in the oncology dr ug market is expected to be 7.5 &ndash\; 10.5 percent through 2020\, reach ing $150 billion. Wider utilization of new products&mdash\;especially immu notherapies&mdash\;will drive much of the growth\, offset by reduced use o f some existing treatments with inferior clinical outcomes. Payers also ar e expected to tighten their negotiation stance with manufacturers and adop t new payment models in an effort to drive greater value from their expend itures on these drugs.
\n\nCancer Science and Therapy are organized Conference Series LLC Ltd which is comprised of 3000+ Global Events with o ver 600+ Conferences\, 1200+ Symposiums and 1200+Workshops on diverse Medi cal\, Pharmaceutical\, Clinical\, Engineering\, Science\, Technology\, Bus iness and Management field is organizing conferences all over the globe. C ancer Therapy 2020 will provide an excellent opportunity for the budding s cientists and young researchers through its special initiatives like Young Researcher Forum\, Poster Presentation and E-poster and Live Streaming\, B2B and Scientific Meetings.
\n\nWhy to attend?
\n\nCancer Therapy 2020 will provide a stimulating scientific environme nt and a platform for the participants to share ideas and knowledge\, coll aborate on Cancer and Oncology related problems and network with other pro fessionals. Discussing on various imperative topics will add an insight to ponder and confer over crux of today&rsquo\;s scientific and technologica l perk up. It will be amazing opportunity for the attendees to explore the beautiful City of Los Angeles with gaining knowledge\, sure to raise insi ghts\, conflate present with future and cogitate on ideas and reality in O ncology meetings. To fight against these hard to cure cancer diseases\, Ca ncer Therapy 2020 has taken this initiative to explore every aspects of Ca ncer research.
\n\nAbout Los Angeles City:
\n\n< p>One of the greatest cities in the world\, Los Angeles is always a whirlw ind of activity\, with famous sites at every turn and never enough time to see them all. L.A. has many famous sights. There are many very long beach es\, such as Venice Beach. Many visitors go to Hollywood\, home to the Hol lywood Walk of Fame and the Mann'\;s (Grauman'\;s) Chinese Theatre\, a large cinema. Los Angeles also has many fine museums such as the L.A. C ounty Museum of Art and the Getty Museum. Another sight is the Los Angeles City Zoo. Los Angeles is the only major city in the world with an active population of wild mountain lions. Each of the City&rsquo\;s five boroughs contains its own roster of must-see destinations\, great restaurants\, cu ltural hot spots and unforgettable activities. Attractions in Los Angeles suit all tastes.\n\nTarget Audience
\n\nThe 26th Annual confe rence on Cancer Science and Therapy is intended for Cancer Specialists\, G ynecologic oncologists\, Medical oncologists\, Radiation oncologists\, Obs tetricians/gynecologists\, fellows and residents\, research scientists\, n urses\, nurse practitioners\, physician assistants\, allied health profess ionals\, and others involved in the care of patients with Oncologic malign ancies.
\n\nLearning Objectives
\n\nA s a result of attending the Annual Conference\, learners will be able to:< /strong>
\n\n&bull\; Interpret contemporary research findings on the prevention of and screening for Cancerous tumours and be able to appropri ately implement these findings into clinical practice\; &bull\; Examine th e significance of novel approaches to the medical and surgical management of Cancerous tumours within the context of the current standard of care an d be able to integrate new therapies into clinical practice in an evidence -based manner\; &bull\; Assess the implications for future research and cl inical practice of new developments in translational research on Cancerous tumours &bull\; Demonstrate improvement in competence\, performance and p atient outcomes\; and &bull\; Identify and explain the latest trends in gl obal research\, methods\, and technology in the treatment of Cancerous tum ours.
\n\nSessions and Tracks Cancer is a class of diseases characterized by out-of-control cell growth. There are more than 100 distinct sorts of cancer and each is ordered by the kind of cell which is first influenced. Malignancy is thought to be one of the main sources of grimness and mortality around the world. More than 575\,000 individuals bite the dust of tumor and more than 1.5 million individuals are determin ed to have disease every year in the US. A restorative expert who hones in the field of cancer and cancer related diseases is an oncologist.
\n\nIn addition to the multidisciplinary talks\, keynote sessions and lectu res relevant to cancer science &\; therapy\, the Cancer Therapy 2020 is a complete 2 days event with panel discussions\, open Q &\; A to gener ate a prime learning knowledge between participants.
\n\nSci entific Session of the Conference includes:
\n\n&bull\; Tar get Therapy
\n\n&bull\; Cancer Immunotherapy &\; Vaccines
\n\n&bull\; Cancer Metabolism
\n\n&bull\; Cancer Epigenomics
\n\n< p>&bull\; Cancer Inflammation and Immune Tolerance\n\n&bull\; Nanop articles in Cancer Therapy
\n\n&bull\; Novel Approaches to Cancer Th erapeutics
\n\n&bull\; Cancer Management &\; Prevention
\n\n&bull\; Cancer Pharmacology
\n\n&bull\; Tumor Virology
\n\n&b ull\; Tumour immunology &\; immunotherapy
\n\n&bull\; Organ-Speci fic Cancer
\n\n&bull\; Cancer Biomarkers
\n\n&bull\; Cancer St em Cell Therapy
\n\n&bull\; Anti-Cancer Agents in Medicinal Chemistr y
\n\n&bull\; Surgical Oncology
\n\n&bull\; Cancer: Psychologi cal &\; Social Aspects
\n\n&bull\; Radiation Oncology
\n\n& bull\; Cancer Chemotherapy
\n\n&bull\; Cancer Diagnostics &\; Dia gnostic Market
\n\n&bull\; Complementary and Alternative Cancer Trea tment
\n\n&bull\; Medical Oncology
\n\n&bull\; Mechanisms of C arcinogenesis
\n\n&bull\; Genetic Cancer Susceptibility
\n\n&b ull\; Infections and Cancer Epidemiology
\n\n&bull\; Etiology of Can cer
\n\n&bull\; Cancer Treatment Research
\n\n&bull\; Cancer G enetics and genomics
\n\n&bull\; Computational Oncology
\n\n&b ull\; Solid Tumour Oncogenesis
\n\n1. Target Therapy
\n\nTargeted therapy is a special type of chemotherapy involves a mechanism of differentiating between cancerous and non-cancerous cells in the body\, attacking only the cancerous ones but not interfering with the normal ones. it is sometimes used alone\, but most often other cancer trea tments are used in combination with targeted therapy.
\n\n&bull\; Th erapeutic Monoclonal Antibodies &bull\; Small Molecule Drugs &bull\; Tyros ine-kinase inhibitors &bull\; Implications of Targeted Therapy &bull\; Tar geted Cancer Therapy &\; Health Economics &bull\; Hormone Therapies
\n\n2. Cancer Immunotherapy &\; Vaccines
\n\nCancer immunotherapy (Immuno-oncology or Immunooncology) is the use of the immune system to treat cancer. Immunotherapies can be categorized as acti ve\, passive or hybrid (active and passive). These approaches exploit the fact that cancer cells often have molecules on their surface that can be d etected by the immune system\, known as tumour-associated antigens (TAAs)\ ; they are often proteins or other macromolecules (e.g. carbohydrates). Ac tive immunotherapy directs the immune system to attack tumor cells by targ eting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies\, lymphocytes and cytokines.< /p>\n\n
&bull\; Nano systems &bull\; Targeted delivery &bull\; Cell trac king &bull\; Immunotherapy &bull\; Tumor biology &bull\; Cancer vaccines p>\n\n
3. Cancer Metabolism
\n\nCancer metabolism refers to the alterations in cellular metabolism pathways that are eviden t in cancer cells compared with most normal tissue cells. Metabolic altera tions in cancer cells are numerous and include aerobic glycolysis\, reduce d oxidative phosphorylation and the increased generation of biosynthetic i ntermediates needed for cell growth and proliferation.
\n\n4 . Cancer Epigenomics
\n\nCancer epigenetics is the study of epigenetic modifications to the genome of cancer cells that do not involv e a change in the nucleotide sequence. Epigenetic alterations are as impor tant as genetic mutations behind the transition of a cell from normal to c ancerous\, and their manipulation holds great promise for cancer preventio n\, detection and therapy. In different types of cancer\, a variety of epi genetic mechanisms can be perturbed\, such as silencing of tumor suppresso r genes and activation of oncogenes by altered CpG island methylation patt erns\, histone modifications and dysregulation of DNA binding proteins.
\n\n&bull\; Cancer genomics &bull\; Epigenetic influence on genomic st ability &bull\; Molecular underpinnings of therapeutic targets &bull\; Abe rrant DNA methylation genes &bull\; Tumor heterogeneity
\n\n5. Cancer Inflammation and Immune Tolerance
\n\nIt is widel y accepted that chronic inflammation critically contributes to cancer. Imm une tolerance in cancer mediates tumor escape from the immune system. Infl ammation mediates tumor-induced tolerance. The induction and the maintenan ce of the chronic inflammatory response is a universal mechanism of immune tolerance.
\n\n6. Nanoparticles in Cancer Therapy< /p>\n\n
Nanoparticles have been of significant interest over the last de cade as they offer great benefits in drug delivery to overcome limitations present in case of conventional chemotherapy. They can not only be formed in a range of sizes (1-1000 nm) but also made by using a variety of mater ials including polymers\, lipids\, inorganic materials and biological mate rials. Using targeted nanoparticles to deliver chemotherapeutic agents in cancer therapy\, offers many advantages to improve drug/gene delivery and to overcome many problems associated with conventional chemotherapy.
\n \n7. Novel Approaches to Cancer Therapeutics
\n\nThe normal treatment modalities are associated with severe side effects a nd high toxicity which in turn lead to low quality of life. This review en compasses novel strategies for more effective chemotherapeutic delivery ai ming to generate better prognosis. Currently\, cancer treatment is a highl y dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics\, novel approaches such as ligand or receptor based targeting \, intracellular drug targeting\, gene delivery\, cancer stem cell therapy \, magnetic drug targeting and ultrasound-mediated drug delivery\, have ad ded new modalities for cancer treatment.
\n\n&bull\; Cancer Epigenet ics &bull\; Molecular Profiling Techniques &bull\; New Biologics &\; Va ccines &bull\; Chemical Proteomics &bull\; Combination Strategies in Immun o-oncology &bull\; Novel Biomarker Discovery
\n\n8. Cancer M anagement &\; Prevention
\n\nTypes of Cancer which are c losely linked to certain behaviours are the easiest to prevent. Many compl ementary health approaches are also found to combat the risks associated w ith cancer like\, for example\, herbal and other dietary supplements\, acu puncture\, massage and yoga.
\n\n&bull\; Lifestyle changes &bull\; D iet &\; Cancer &bull\; Vaccinations &bull\; Natural Therapy &bull\; Psy chological &\; Social Aspects
\n\n9. Cancer Pharmacology< /strong>
\n\nCancer pharmacology plays a key role in drug developmen t. In both the laboratory and the clinic\, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimenta l models and target orientated approaches.
\n\n10. Tumor Vir ology
\n\nSince its inception\, the field of tumor virology has provided ground-breaking insights into the causes of human cancer. Tu mor virologists additionally recognized that viruses could serve as powerf ul discovery tools\, leading to revolutionary breakthroughs in the 1970s a nd 1980s that included the concept of the oncogene\, the identification of the p53 tumor suppressor\, and the function of the retinoblastoma tumor s uppressor. This rich history promises that tumor virology will continue to contribute to our understanding of cancer and to the development of new t herapeutic and preventive measures for this disease
\n\n11. Tumour immunology &\; immunotherapy
\n\nTumor Immunology and Immunotherapy focuses on recent advances in understanding the range o f immune responses towards cancer and how these can be modified and harnes sed for prevention and therapeutics.
\n\n12. Organ-Specific Cancer
\n\nMalignancy has a differentiated nature in connec tion to the organ specificity. The essential focus is on heterogeneity\, s tarting point\, metastasis\, angiogenesis and organ indicated systems in d isease cells. There is a diverse spectrum of diseases\, taking into accoun t the area of tumor in the body organ. Organ-particular metastasis include s disease cell collaborations with the host micro-environment\, including actuation of paracrine cytokine circles\, change of the host cell synthesi s\, and modification of extracellular framework structures.
\n\nA cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific res ponse of the body to the presence of cancer. Genetic\, epigenetic\, proteo mic\, glycomic\, and imaging biomarkers can be used for cancer diagnosis\, prognosis\, and epidemiology. Ideally\, such biomarkers can be assayed in non-invasively collected bio-fluids like blood or serum.
\n\n&bull\ ; Imaging Biomarkers &bull\; Clinical Biomarkers &bull\; Genetic Biomarker s &bull\; Predictive Cancer Biomarkers &bull\; Molecular Biomarkers &bull\ ; Cell Free Biomarkers
\n\n14. Cancer Stem Cell Therapy
\n\nStem cell transplants are procedures that restore blood-for ming stem cells in people who have had theirs destroyed by the very high d oses of chemotherapy or radiation therapy that are used to treat certain c ancers. Blood-forming stem cells are important because they grow into diff erent types of blood cells.
\n\n&bull\; Cancer Stem Cells &bull\; St em Cells and Tumors &bull\; Stem Cell Transplantation &bull\; Bone Marrow Transplantation &bull\; Cord Blood Stem Cells and Cancer &bull\; Stem Cell Research
\n\n15. Anti-Cancer Agents in Medicinal Chemistry< /strong>
\n\nAnti-Cancer agents in Medicinal Chemistry aim to cover all the latest and outstanding developments in medicinal chemistry and rat ional drug design for the discovery of anti-cancer agents. Anti-Cancer Age nts in Medicinal Chemistry is an essential journal for every medicinal che mist who wishes to be kept informed and up-to-date with the latest and mos t important developments in cancer drug discovery.
\n\n16. S urgical Oncology
\n\nSurgical oncology is a specialty that focuses on the surgical treatment of a variety of tumors. Ephraim McDowell did the first reported resection of an ovarian tumor in 1809\, but as ear ly as the 7th century\, ancient Egyptians described techniques for removin g breast tumors.
\n\n17. Cancer: Psychological &\; Social Aspects
\n\nCancer treatments today are likely to cause le ss physical deformity from surgery than a half-century ago\, but are more complex and extend over a longer period of time. People today are often we ll informed about the details of their cancer diagnosis and prognosis\, an d are increasingly involved in shared decision-making regarding treatment. Although serious depression is not seen in the majority of cancer patient s and survivors\, many will experience treatment-related distress\, fear o f recurrence\, changes in body image and sexuality\, as well as physical t oxicities that result from adjuvant therapy. It is important to identify t he psychological and social concerns of cancer patients in the medical set ting\, and assisting them in obtaining appropriate psychosocial services.< /p>\n\n
18. Radiation Oncology
\n\nRadiation onco logy is a medical speciality that involves the controlled use of radiation to treat cancer either for cure\, or to reduce pain and other symptoms ca used by cancer. Radiation therapy (also called radiotherapy) is the term u sed to describe the actual treatment delivered by the radiation oncology t eam.
\n\n19. Cancer Chemotherapy
\n\nThe word chemotherapy means drugs used for cancer treatment. It&rsquo\;s often sho rtened to &ldquo\;chemo.&rdquo\; Surgery and radiation therapy remove\, ki ll\, or damage cancer cells in a certain area\, but chemo can work through out the whole body. This means chemo can kill cancer cells that have sprea d (metastasized) to parts of the body far away from the original (primary) tumor.
\n\n20. Cancer Diagnostics &\; Diagnostic Market< /strong>
\n\nCancer diagnostics market is witnessing high growth due to increasing prevalence and incidences of several types of cancers. Majo r drivers for the global cancer diagnostic market are technologically adva nced and increasing point-of-care diagnostics\, cost-effective treatment m odalities and personalized medicine. Additionally\, increasing persistence to provide best-in-class healthcare services with high accuracy and effic iency towards patient is expected to fuel the global cancer diagnostics ma rket across the globe.
\n\n21. Complementary and Alternative Cancer Treatment
\n\nAlternative cancer treatments may not play a direct role in curing the cancer\, but they may help in coping up with the signs and symptoms caused by cancer and cancer treatments. CAM (C omplementary and Alternative Medicine) is the term for medical products an d practices that are not part of standard care.Integrating the best of evi dence-based complementary and alternative cancer treatments with the treat ments you receive from your doctor may help relieve many of the symptoms a ssociated with cancer and its treatment.
\n\n22. Medical Onc ology
\n\nAlternative cancer treatments may not play a dire ct role in curing the cancer\, but they may help in coping up with the sig ns and symptoms caused by cancer and cancer treatments. CAM (Complementary and Alternative Medicine) is the term for medical products and practices that are not part of standard care.Integrating the best of evidence-based complementary and alternative cancer treatments with the treatments you re ceive from your doctor may help relieve many of the symptoms associated wi th cancer and its treatment.
\n\n23. Mechanisms of Carcinoge nesis
\n\nCarcinogenesis\, also called oncogenesis or tumor igenesis\, is the mechanism of formation of a cancer\, where normal cells are transformed into cancer cells. The process is characterized by changes at the cellular\, genetic\, and epigenetic levels and abnormal cell divis ion.
\n\n24. Genetic Cancer Susceptibility
\n\n< p>Carcinogenesis\, also called oncogenesis or tumorigenesis\, is the mecha nism of formation of a cancer\, where normal cells are transformed into ca ncer cells. The process is characterized by changes at the cellular\, gene tic\, and epigenetic levels and abnormal cell division.\n\n25. Infections and Cancer Epidemiology
\n\nAs persistent in fection with viruses\, bacteria\, or parasites is a predominant cause of h uman cancer\, notably in low- and middle-income countries\, Infections and Cancer Epidemiology contributes substantially to IARC&prime\;s mission of cancer prevention in the most vulnerable populations.
\n\n2 6. Etiology of Cancer
\n\nThe Infections and Cancer Epidemi ology Group (ICE) has estimated that approximately 2 million cancer cases worldwide can be attributed to infectious agents. Promoting human papillom avirus (HPV) vaccination and cervical screening programmes for the prevent ion of cervical cancer is an ICE priority. However\, other associations be tween infectious agents and cancer require additional research and better standardized control measures.
\n\n27. Cancer Treatment Rese arch
\n\nCancer treatments that target the specific changes \, most often in proteins\, that underlie the growth and development of ca ncer. Surgery\, radiation therapy\, and standard chemotherapy will continu e to play an important role in treating cancer\, but the emergence of targ eted therapies and of immunotherapies\,in the recent years\, which harness the power of the immune system to fight cancer\, have expanded the treatm ent options available to patients with certain types of cancer.
\n\n28. Cancer Genetics and genomics
\n\nThe Cancer Gen etics and Genomics (CGG) Program serves to coordinate the research activit ies related to the study and understanding of cancer genomics\, epigenetic s\, gene expression\, model systems and host interactions. The CGG is at t he forefront of applying '\;omics'\; technologies that assess altera tions in cancer genomes\, epigenomes and transcriptomes\, or techniques th at are capable of editing the genome or epigenome of a model system. The p rogram serves as the primary source of expertise for these aspects of canc er.
\n\n&bull\; Tumor cell proliferation &bull\; Genetic Studies &bu ll\; The Cancer Genome Atlas (TCGA) &bull\; Genetic Tools &bull\; Metaboli c Technologies &bull\; Data Interpretations
\n\n29. Computat ional Oncology
\n\nThe field of computational oncology has forged a new relationship between the physical sciences and oncology to fu rther advance research. By applying physics and mathematics to oncologic p roblems\, new insights will emerge into the pathogenesis and treatment of malignancies. One major area of investigation in computational oncology ce ntres around the acquisition and analysis of data\, using improved computi ng hardware and software. Large databases of cellular pathways are being a nalyzed to understand the interrelationship amongst complex biological pro cesses.
\n\n30. Solid Tumour Oncogenesis
\n\nOncogene amplifications have been shown in solid human cancers and they ar e often associated with progression of cancer. Defining oncogene amplifica tion is useful since it is used as a prognostic marker in clinical oncolog y nowadays\, especially v-erb-b2 avian erythroblastic leukemia viral oncog ene homolog 2 (HER2) targeted agents are used in breast cancer patients wi th high level of HER2 overexpression as a therapeutic approach.
\n\nPlease contact the event manager Marilyn (marilyn.b.turner(at)nyeven tslist.com ) below for: - Multiple participant discounts - Price quotation s or visa invitation letters - Payment by alternate channels (PayPal\, che ck\, Western Union\, wire transfers etc) - Event sponsorship NO REFUNDS AL LOWED ON REGISTRATIONS Prices may go up any time. Service fees included in pricing. ---------------------------------------------------------------- - This event is brought to you by: Conference Series - NewYorkEventsList h ttp://www.NyEventsList.com http://www.BostonEventsList.com http://www.SFBa yEventsList.com ---------------------------------------------------------- -------
\n\nVIO180518CRE MYL180626UPA
\n
\nPl
ease contact Marilyn Turner: Phone: +1 929 900 1853 \; Email: marilyn.
turner [a] nyeventslist.com for registrations